Are we measuring aging all wrong? A groundbreaking new study in Genomic Psychiatry challenges the very foundations of how we understand and quantify biological aging, urging scientists to rethink their approaches. Led by Dr. Dan Ehninger of the Translational Biogerontology Laboratory at the German Center for Neurodegenerative Diseases and Dr. Maryam Keshavarz, this review systematically dissects the tools and frameworks commonly used to study aging—from lifespan extension to epigenetic clocks and frailty indices. But here's where it gets controversial: many of these methods, they argue, might be confusing age-independent physiological changes with genuine alterations in aging itself. And this is the part most people miss: living longer doesn’t necessarily mean aging slower.
Take the Lifespan Paradox, for instance. In humans, cardiovascular disease dominates as the leading cause of death in older adults, even among centenarians. Yet, across species, the story changes dramatically. Mice succumb mostly to cancer, dogs to neoplasia, and nonhuman primates mirror humans with cardiovascular issues. Even invertebrates like Drosophila and C. elegans face species-specific bottlenecks. This raises a provocative question: Are we extending life by treating specific diseases, or are we truly slowing down aging?
The authors draw parallels to the Epidemiologic Transition, where advancements in medicine shifted the primary causes of death from infectious diseases to chronic conditions, but didn’t necessarily slow aging. This historical insight is crucial for today’s research. If interventions target specific pathologies without broadly modifying aging, how can we accurately interpret their effects? For example, delaying cancer in mice might extend lifespan, but does it truly slow systemic aging? Is modern aging research missing the forest for the trees?
The Clock Conundrum adds another layer of complexity. Aging clocks, particularly those based on DNA methylation, are popular for estimating biological age. But do they measure causation or merely correlation? The authors liken it to predicting age from facial wrinkles—predictive, but not insightful into the underlying biology. Recent studies support this, showing that traditional aging clocks aren’t significantly enriched for CpG sites with causal roles in aging. Are we mistaking biomarkers for mechanisms?
Frailty indices, too, have their limitations. By summing diverse deficits into a single score, they might overstate the impact of improvements in specific pathologies, giving a false impression of broad anti-aging effects. Similarly, the Hallmarks of Aging framework, while influential, faces scrutiny. The authors found that most studies supporting these hallmarks lack parallel assessments in young treated cohorts, making it impossible to distinguish between age-independent effects and true aging modulation. Is the foundation of aging research built on shaky ground?
To address these gaps, the authors propose a Methodological Framework distinguishing between baseline effects (age-independent changes) and rate effects (slowing of age-dependent decline). They emphasize the need for multitissue phenotype panels, inclusive study designs, and careful interpretation of results. But here’s the kicker: If we’re not measuring aging correctly, are we wasting resources on interventions that only treat symptoms rather than targeting the root causes?
This review isn’t just an academic exercise—it has profound implications for drug development, clinical trials, and patient care. It challenges us to ask: What does it truly mean to modify aging? And how can we ensure that our research translates into interventions that fundamentally alter the aging process, not just its symptoms?
As we grapple with these questions, one thing is clear: the field of aging research is at a crossroads. Will we continue down well-trodden paths, or will we embrace the complexity and uncertainty of redefining aging itself? What do you think—are we measuring aging all wrong, or is this critique overstated? Share your thoughts in the comments below!
